Summary
- Current Price
- As of today, ESPR price is $2.04, down -0.49% on
- Current Price All-Time High
- ESPR price is currently -98.31% below its historical high of $120.96 set on
- Market Cap
- ESPR current market cap is $525M, up +178.95% over the past 365 days
- PE Ratio
- ESPR PE ratio is unknown
- Revenue
- ESPR current annual revenue is $403.14M, up +21.31% year-over-year
- Next Earnings
- The next earnings release for ESPR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Esperion Therapeutics, Inc. |
| Ticker | NASDAQ: ESPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | esperion.com |
| Employees | 304 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.04 | |
| Price, 1D Change | -0.49% | |
| $525M | ||
| - | ||
| - | ||
| 2.21 | ||
| $403M | ||
| Revenue, 1Y Change | +21.31% | |
| -$0.11 | ||
| EPS, 1Y Change | +60.53% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.11 | ||
| EPS Estimate | N/A | $0.01 |
| EPS Est. Change | N/A | +112.19% |
| $403.14M | ||
| Revenue Estimate | N/A | $420.13M |
| Revenue Est. Change | N/A | +4.21% |
| Current Price | $2.04 | |
| Price Target | - | $5.16 |
| Price Tgt. Change | - | +152.94% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.33 | -$0.28 | +16.24% | |
| -$0.05 | -$0.11 | -118.20% | |
| $0.01 | N/A | +112.19% | |
| $0.29 | N/A | +368.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $324.73M | $332.31M | +2.33% | |
| $402.10M | $403.14M | +0.26% | |
| $420.13M | N/A | +4.21% | |
| $455.44M | N/A | +12.97% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.04 | |
| $2.75 | ||
| SMA 200 vs Price | +34.80% | |
| $2.83 | ||
| SMA 50 vs Price | +38.74% | |
| 2.21 | ||
| $0.20 | ||
| 32.51 | ||
| 76.89% | ||
| 83.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $403.14M | ||
| -$0.11 | ||
| $273.91M | ||
| 67.95% | ||
| $60.27M | ||
| 14.95% | ||
| -$22.68M | ||
| -5.63% | ||
| $60.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.81 | ||
| 1.54 | ||
| 1.19 | ||
| - | ||
| 5 | ||
| -1.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.30 | ||
| -1.74 | ||
| 15.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$301.96M | ||
| $167.85M | ||
| $883.74M | ||
| $462.57M | ||
| $1.19B | ||
| $300.81M | ||
| $548.00M | ||
| $89.70M | ||
| $65.07M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $425.82M | ||
| $213.64M | ||
| $129.22M | ||
| $0.00 | ||
| $105.00K | ||
| $0.00 | ||
| $1.84M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$13.09M | ||
| $0.00 | ||
| $36.18M | ||
| $0.00 | ||
| -$13.09M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | → | |
| Needham | → | |
| Piper Sandler | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with ESPR
FAQ
What is the ticker symbol for Esperion Therapeutics, Inc.?
The ticker symbol for Esperion Therapeutics, Inc. is NASDAQ:ESPR
Does Esperion Therapeutics, Inc. pay dividends?
No, Esperion Therapeutics, Inc. does not pay dividends
What sector is Esperion Therapeutics, Inc. in?
Esperion Therapeutics, Inc. is in the Healthcare sector
What industry is Esperion Therapeutics, Inc. in?
Esperion Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Esperion Therapeutics, Inc. based in?
Esperion Therapeutics, Inc. is headquartered in United States
When did Esperion Therapeutics, Inc. go public?
Esperion Therapeutics, Inc. initial public offering (IPO) was on June 26, 2013
Is Esperion Therapeutics, Inc. in the S&P 500?
No, Esperion Therapeutics, Inc. is not included in the S&P 500 index
Is Esperion Therapeutics, Inc. in the NASDAQ 100?
No, Esperion Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Esperion Therapeutics, Inc. in the Dow Jones?
No, Esperion Therapeutics, Inc. is not included in the Dow Jones index
When was Esperion Therapeutics, Inc. last earnings report?
Esperion Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Esperion Therapeutics, Inc. report earnings?
The next expected earnings date for Esperion Therapeutics, Inc. is May 5, 2026
Data Sources & References
- ESPR Official Website www.esperion.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1434868/000162828026016522/0001628280-26-016522-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434868/000162828026016522/0001628280-26-016522-index.htm
- ESPR Profile on Yahoo Finance finance.yahoo.com/quote/ESPR
- ESPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/espr